Reuters logo
17 天内
BRIEF-Argenx presents data from ARGX-111 phase Ib study
2017年7月7日 / 凌晨5点10分 / 17 天内

BRIEF-Argenx presents data from ARGX-111 phase Ib study

1 分钟阅读

July 7 (Reuters) - Argenx NV:

* ARGENX PRESENTS FULL DATA FROM ARGX-111 PHASE IB STUDY IN PATIENTS WITH ADVANCED CANCERS OVER-EXPRESSING THE MET PROTEIN AT BEST OF ASCO ASIA 2017 (SINGAPORE) Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below